Furthermore, the literature demonstrates that S6K2 inhibits apoptosis in lung cancer (Pardo et al., 2006) and that S6K2 amplification is associated with more aggressive forms of breast cancer (Pérez-Tenorio et al., 2011). This evidence concerns the gene RPS6KB2 and breast cancer.